Posted October 16, 2020
The synthetic estrogen Diesthylstilbestrol (DES) was prescribed to pregnant women in the U.S. from 1938 to 1971 for the prevention of miscarriages and premature births. In 1953, published research showed that DES did not in fact prevent miscarriages or premature births. However, physicians continued to prescribe it until 1971, when the FDA warned that the drug could cause cancer in women exposed to DES in the womb.  Read more.